This inventor holds 2 USPTO granted patents. Top assignees: University of Georgia Research Foundation Inc, Biology Centre Cas, V.v.i., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2016.
Company Filing History:
2 out of 870 
1 out of 1 
1 out of 3,690 
Years Active: 2016
Title: Michael Strand: Innovator in Genetic Engineering and Anticoagulant Research
Introduction
Michael Strand is a notable inventor based in Athens, GA (US), recognized for his contributions to genetic engineering and the development of novel anticoagulants. With a total of 2 patents, Strand has made significant strides in the field of biotechnology.
Latest Patents
Strand's latest patents include groundbreaking work on polydnavirus delivery constructs. This invention provides methods for producing genetically modified cells by introducing a polydnavirus delivery construct to a target cell. The constructs can comprise exogenous nucleic acids, leading to the formation of genetically modified cells. Additionally, he has developed methods for identifying transformed cells through the expression of a glc polypeptide, which results in a loss of adherency in the cells. Another significant invention is simukunin, a novel protein that acts as a potent inhibitor of the blood coagulation cascade. Simukunin inhibits Factor Xa and serves as an efficient anticoagulant, while also demonstrating anti-inflammatory properties.
Career Highlights
Throughout his career, Michael Strand has worked with esteemed organizations such as the University of Georgia Research Foundation Inc and the United States Department of Health and Human Services. His work has contributed to advancements in both genetic engineering and therapeutic applications.
Collaborations
Strand has collaborated with notable individuals in his field, including Donald Champagne and Ivo M Francischetti. These partnerships have further enhanced his research and innovation efforts.
Conclusion
Michael Strand's innovative work in genetic engineering and anticoagulant research highlights his significant contributions to biotechnology. His patents reflect a commitment to advancing scientific knowledge and improving health outcomes.